Hyam Levitsky
Chief Tech/Sci/R&D Officer chez CENTURY THERAPEUTICS, INC.
Fortune : 2 M $ au 29/02/2024
Profil
Hyam I.
Levitsky holds the position of President-Research & Development at Century Therapeutics, Inc. Dr. Levitsky is also on the board of Replimune Group, Inc. and Prokarium Ltd.
and Member-Cancer Immunotherapy Consortium at Cancer Research Institute, Member of American Association for Cancer Research and Member of American Society of Hematology.
In his past career Dr. Levitsky was President-Research & Development at Century Therapeutics, Inc. and President-Research & Development at Century Therapeutics, Inc. (a subsidiary of Century Therapeutics, Inc.), Head-Cancer Immunology Experimental Medicine at Roche Holding AG Head-Cancer Immunotherapy Experimental Medicine at F.
Hoffmann-La Roche Ltd.
and Head-Cancer Immunology at Roche Pharmaceuticals, Inc. (both are subsidiaries of Roche Holding AG), Member of American Society for Clinical Investigation, Chief Scientific Officer & Executive VP at Juno Therapeutics, Inc., Scientific Director at The Johns Hopkins University, Professor at The Sidney Kimmel Comprehensive Cancer Center and Professor at The Johns Hopkins University School of Medicine.
He received an undergraduate degree from School of Engineering & Applied Science and a doctorate from The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
07/03/2024 | 560 544 ( 0,94% ) | 2 M $ | 29/02/2024 | |
REPLIMUNE GROUP, INC.
-.--% | 30/06/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Postes actifs de Hyam Levitsky
Sociétés | Poste | Début |
---|---|---|
REPLIMUNE GROUP, INC. | Director/Board Member | 01/05/2018 |
CENTURY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 11/04/2023 |
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Director/Board Member | 01/10/2020 |
Cancer Research Institute
Cancer Research Institute Medical/Nursing ServicesHealth Services Cancer Research Institute provides cancer immunotherapy services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded in 1953. Jill O'Donnell-Tormey has been the CEO of the company since 1987. | Corporate Officer/Principal | - |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Anciens postes connus de Hyam Levitsky
Sociétés | Poste | Fin |
---|---|---|
CENTURY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
JUNO THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/04/2018 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01/02/2015 |
░░ ░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Hyam Levitsky
The Johns Hopkins University School of Medicine | Doctorate Degree |
School of Engineering & Applied Science | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
ROCHE HOLDING AG | Health Technology |
AGENUS INC. | Health Technology |
REPLIMUNE GROUP, INC. | Health Technology |
CARISMA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 11 |
---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Cancer Research Institute
Cancer Research Institute Medical/Nursing ServicesHealth Services Cancer Research Institute provides cancer immunotherapy services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded in 1953. Jill O'Donnell-Tormey has been the CEO of the company since 1987. | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Health Technology |
The Sidney Kimmel Comprehensive Cancer Center
The Sidney Kimmel Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services The Sidney Kimmel Comprehensive Cancer Center offers immune-based treatments for cancer. The company was founded by Sidney Kimmel in 1973 and is headquartered in Baltimore, MD. | Health Services |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Commercial Services |
Century Therapeutics, Inc. | |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Century Therapeutics, Inc. operates as a biotechnology company. It develops transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need. The company has created a allogeneic cell therapy platform that includes induced pluripotent stem cells, or iPSCs, differentiation know-how to generate immune effector cells from iPSCs, or iPSC-derived cells, clustered regularly interspaced short palindromic repeats, or CRISPR, mediated precision gene editing that allows it to incorporate multiple transgenes and remove target genes intended to optimize cell product performance, sophisticated protein engineering capabilities to develop proprietary next generation chimeric antigen receptors, or CARs, its proprietary Allo-EvasionTM technology intended to prevent rejection of its cell products by the host immune system, and cutting edge manufacturing capabilities intended to minimize product development and supply risk. Century Therapeutics was founded on March 5th, 2018 and is headquartered by Philadelphia, PA. | Health Technology |